Lord, Abbett & Co’s ICU Medical ICUI Stock Holding History

Lord, Abbett & Co’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-74,150	Closed	-$10.9M	–	892
2016 Q4	$10.9M	Buy	+74,150	New	+$10.7M	0.03%	543

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co's ICUI Position: Q1 2017 in Review

Lord, Abbett & Co sold out of ICU Medical (ICUI) in Q1 2017, closing a stake of 74,150 shares — an estimated $10.9M sold.

Lord, Abbett & Co first reported a position in ICUI in Q4 2016 and held it in 1 quarter. The position peaked at $10.9M in Q4 2016. 230 funds tracked by Wall St. Rank hold ICUI as of Q1 2017.

Lord, Abbett & Co reported no remaining ICU Medical position as of Q1 2017 after selling out during the quarter.
Lord, Abbett & Co sold 74,150 ICU Medical shares in Q1 2017, an estimated $10.9M.
Lord, Abbett & Co first reported a position in ICU Medical in Q4 2016 and held it in 1 quarter.
Lord, Abbett & Co's ICU Medical position peaked at $10.9M in Q4 2016.
230 funds tracked by Wall St. Rank held ICU Medical as of Q1 2017.

Based on Lord, Abbett & Co's 13F filing for Q1 2017, filed 15 May 2017.